Introduction
At Axeusce, we understand that high-quality evidence synthesis is essential for advancing clinical decision-making. Meta-analysis remains one of the most powerful statistical tools in evidence-based medicine, allowing researchers to combine data from multiple studies to generate precise and reliable pooled estimates.
Using STATA for meta-analysis provides medical researchers with a flexible, accurate, and publication-ready framework for statistical synthesis. This professional guide by Axeusce outlines the core steps required to perform meta-analysis with STATA in clinical research.
Why Medical Researchers Choose STATA – Recommended by Axeusce
At Axeusce, we frequently use STATA for systematic reviews and meta-analyses because it offers:
-
Advanced random-effects modeling
-
Built-in heterogeneity statistics
-
High-quality forest and funnel plots
-
Meta-regression capabilities
-
Publication-standard outputs accepted by peer-reviewed journals
For clinical researchers conducting therapeutic, diagnostic, or epidemiological studies, STATA provides methodological precision that aligns with international reporting standards.
Data Preparation for Meta-Analysis (Axeusce Methodological Approach)
Before running meta-analysis in STATA, Axeusce recommends extracting:
-
Effect size (Odds Ratio, Risk Ratio, Hazard Ratio, Mean Difference)
-
Standard error or 95% confidence interval
-
Sample size
-
Study identification variables
For ratio measures, effect sizes should be transformed into logarithmic form (e.g., log OR) to ensure accurate variance estimation.
Conducting Random-Effects Meta-Analysis in STATA
Because most clinical studies differ in population, intervention, and methodology, Axeusce typically recommends a random-effects model.
After loading your dataset:
meta set logeffect se
meta summarize, random
The random-effects model accounts for both within-study and between-study variability, making it more appropriate for medical research settings.
Assessing Heterogeneity in Clinical Meta-Analysis
STATA provides:
-
I² statistic
-
Tau² (between-study variance)
-
Cochran’s Q test
At Axeusce, we interpret heterogeneity as:
-
I² < 25% → Low
-
25–50% → Moderate
-
50% → Substantial
High heterogeneity requires subgroup analysis or meta-regression for deeper clinical interpretation.
Forest Plot Interpretation – Axeusce Reporting Standard
Generate a forest plot: meta forestplot
In all Axeusce-supported publications, the forest plot includes:
-
Individual study weights
-
95% confidence intervals
-
Pooled effect size
-
Heterogeneity statistics
This ensures clarity and transparency for journal reviewers and readers.
Publication Bias Assessment
To assess small-study effects:
